treatment protocol to follow with drugs and dosage in detail for pancreatitis in dogs and cat with sign and symtoms step by step gudance

Reading File
Finding Sources
Searching PubMed

pancreatitis dogs cats treatment protocol

Searching the Web

pancreatitis dogs cats treatment protocol drugs dosage 2024 veterinary

Reading Web Page

https://www.msdvetmanual.com/digestive-system/the-exocrine-p…

Finding Sources
Searching PubMed

canine feline pancreatitis management

Reading Web Page

https://todaysveterinarypractice.com/wp-content/uploads/site…

Searching Images

pancreatitis dog cat abdominal pain vomiting clinical signs

This diagnostic imaging set consists of two T2-weighted magnetic resonance imaging (MRI) sequences, presenting a coronal (a) and an axial (b) view of the upper abdomen in a pregnant patient. The images demonstrate classic radiological signs of acute pancreatitis. Key findings marked by white arrows include prominent peripancreatic fat stranding and localized fluid collections characterized by increased T2 signal intensity. These inflammatory changes are seen interdigitating through the pancreatic parenchyma, indicating diffuse interstitial edema. The pancreas itself appears mildly enlarged. Additionally, the coronal view (a) shows the gravid uterus in the lower abdomen, demonstrating the clinical context of managing acute abdominal pain during pregnancy. The T2-weighted modality is utilized here for its high sensitivity to soft tissue edema and fluid, providing a safe diagnostic alternative to ionizing radiation for evaluating pancreatic inflammation and associated complications.

This diagnostic imaging set consists of two T2-weighted magnetic resonance imaging (MRI) sequences, presenting a coronal (a) and an axial (b) view of the upper abdomen in a pregnant patient. The images demonstrate classic radiological signs of acute pancreatitis. Key findings marked by white arrows include prominent peripancreatic fat stranding and localized fluid collections characterized by increased T2 signal intensity. These inflammatory changes are seen interdigitating through the pancreatic parenchyma, indicating diffuse interstitial edema. The pancreas itself appears mildly enlarged. Additionally, the coronal view (a) shows the gravid uterus in the lower abdomen, demonstrating the clinical context of managing acute abdominal pain during pregnancy. The T2-weighted modality is utilized here for its high sensitivity to soft tissue edema and fluid, providing a safe diagnostic alternative to ionizing radiation for evaluating pancreatic inflammation and associated complications.

A series of clinical photographs arranged in a grid to demonstrate self-motor-control rehabilitation exercises for the trunk and core muscles. Panel A, titled 'cat-dog,' shows a patient in a quadruped position performing spinal mobility exercises. The top image illustrates lumbar kyphosis and posterior pelvic tilt (cat stretch), while the bottom image shows lumbar lordosis and anterior pelvic tilt (cow/dog stretch). Panel B, 'draw-in,' demonstrates deep abdominal muscle activation in a supine position. The patient is shown with knees bent, using controlled exhalation and abdominal hollowing, indicated by white arrows pointing toward the spine. Panel C, 'bridge,' depicts a hip extension exercise where the patient, in a supine position with knees flexed and feet planted, elevates the pelvis and torso to create a straight line from the knees to the shoulders, marked by a white guiding line. This visual aid is intended for orthopedic or physical therapy contexts, specifically targeting low back pain management and core stabilization training.

A series of clinical photographs arranged in a grid to demonstrate self-motor-control rehabilitation exercises for the trunk and core muscles. Panel A, titled 'cat-dog,' shows a patient in a quadruped position performing spinal mobility exercises. The top image illustrates lumbar kyphosis and posterior pelvic tilt (cat stretch), while the bottom image shows lumbar lordosis and anterior pelvic tilt (cow/dog stretch). Panel B, 'draw-in,' demonstrates deep abdominal muscle activation in a supine position. The patient is shown with knees bent, using controlled exhalation and abdominal hollowing, indicated by white arrows pointing toward the spine. Panel C, 'bridge,' depicts a hip extension exercise where the patient, in a supine position with knees flexed and feet planted, elevates the pelvis and torso to create a straight line from the knees to the shoulders, marked by a white guiding line. This visual aid is intended for orthopedic or physical therapy contexts, specifically targeting low back pain management and core stabilization training.

<table>
  <tr>
    <td></td>
    <td>Clinical symptoms and signs</td>
  </tr>
  <tr>
    <td>Mucosal involvement</td>
    <td>
      EoG: abdominal pain/cramping, bloating, vomiting, anorexia, weight loss, early satiety, hematemesis, heartburn, dyspepsia, melena, iron deficiency anemia, protein loss, and ulceration with or without perforation.<br><br>
      EoD/EoJ/EoI/EoN: diarrhea, abdominal pain, nausea, vomiting, ulceration with or without perforation, iron deficiency anemia and protein loss.<br><br>
      EoC: abdominal pain, nausea, vomiting, tenesmus, diarrhea and hematochezia or constipation.
    </td>
  </tr>
  <tr>
    <td>Muscular involvement</td>
    <td>
      EoG: abdominal pain and persisting vomiting, pyloric stenosis.<br><br>
      EoD/EoJ/EoI/EoN/EoC: obstructive symptoms (<i>abdominal pain, persistent vomiting, abdominal distension, severe constipation</i>), intussusception, perforation.
    </td>
  </tr>
  <tr>
    <td>Subserosal involvement</td>
    <td>
      EoD/EoJ/EoI/EoN/EoC: abdominal distention, ascites.
    </td>
  </tr>
</table>

<table> <tr> <td></td> <td>Clinical symptoms and signs</td> </tr> <tr> <td>Mucosal involvement</td> <td> EoG: abdominal pain/cramping, bloating, vomiting, anorexia, weight loss, early satiety, hematemesis, heartburn, dyspepsia, melena, iron deficiency anemia, protein loss, and ulceration with or without perforation.<br><br> EoD/EoJ/EoI/EoN: diarrhea, abdominal pain, nausea, vomiting, ulceration with or without perforation, iron deficiency anemia and protein loss.<br><br> EoC: abdominal pain, nausea, vomiting, tenesmus, diarrhea and hematochezia or constipation. </td> </tr> <tr> <td>Muscular involvement</td> <td> EoG: abdominal pain and persisting vomiting, pyloric stenosis.<br><br> EoD/EoJ/EoI/EoN/EoC: obstructive symptoms (<i>abdominal pain, persistent vomiting, abdominal distension, severe constipation</i>), intussusception, perforation. </td> </tr> <tr> <td>Subserosal involvement</td> <td> EoD/EoJ/EoI/EoN/EoC: abdominal distention, ascites. </td> </tr> </table>

I now have comprehensive, detailed information from authoritative veterinary sources (MSD Veterinary Manual 2024, AVMA Journal 2024, Today's Veterinary Practice 2024). Let me compile the complete treatment guide.

Pancreatitis in Dogs and Cats: Complete Clinical Guide

Overview

Pancreatitis is the most common exocrine pancreatic disorder in both dogs and cats. It results from premature activation of digestive enzymes within the pancreas, causing autodigestion and inflammation. Severity ranges from mild/subclinical to necrotizing/life-threatening.

PART 1 - CLINICAL SIGNS AND SYMPTOMS

Dogs

SeveritySigns
MildAnorexia, lethargy, mild diarrhea, vague abdominal discomfort
ModerateVomiting (often repeated), abdominal pain, dehydration, depression
SevereCranial abdominal pain ("prayer posture" - elbows down, hindquarters raised), profuse vomiting, severe dehydration, weakness, fever, icterus, tachycardia, tachypnea, shock
Prayer posture - the classic sign: front legs lowered, rear elevated - is a direct indicator of cranial abdominal pain. Some stoic dogs show only restlessness, trembling, reluctance to move, or vocalization.

Cats

Feline signs are less specific and more subtle than dogs:
  • Anorexia (most common)
  • Lethargy/depression
  • Dehydration
  • Weight loss
  • Hypothermia (more common than fever in cats)
  • Vomiting (less frequent than in dogs)
  • Icterus (jaundice)
  • Abdominal pain (often occult)
  • Palpable abdominal mass (rare)
Key difference: Cats rarely show the dramatic vomiting and "prayer posture" seen in dogs. Many cats with pancreatitis present with only lethargy and anorexia. Also, cats commonly have concurrent triaditis - pancreatitis + cholangitis + inflammatory bowel disease occurring together.

PART 2 - DIAGNOSIS

Step 1: History and Physical Exam

  • Diet history (high-fat meal trigger in dogs)
  • Drug history: phenobarbital, potassium bromide, L-asparaginase, azathioprine can cause pancreatitis
  • Assess dehydration, pain score (modified Glasgow scale), body condition

Step 2: Bloodwork

  • CBC: Leukocytosis (neutrophilia), possible anemia
  • Biochemistry: Elevated ALT/AST, hyperbilirubinemia, azotemia (pre-renal), hyperglycemia, hypoalbuminemia, hyperlipidemia
  • Electrolytes: Hypokalemia, hyponatremia common

Step 3: Lipase Testing (GOLD STANDARD)

  • Dogs: Spec cPL (specific canine pancreatic lipase) - >400 mcg/L confirms pancreatitis; 200-400 mcg/L = equivocal. SNAP cPL for in-clinic screening.
  • Cats: Spec fPL - >12 mcg/L suggests pancreatitis; >28 mcg/L confirms pancreatitis. SNAP fPL for in-clinic screening.

Step 4: Imaging

  • Abdominal radiographs: Decreased contrast in cranial abdomen, "ground glass" appearance, duodenal displacement (dogs); usually normal (cats)
  • Abdominal ultrasound: Preferred - hypoechoic pancreas, hyperechoic peripancreatic fat, free fluid, pancreatic enlargement

PART 3 - SEVERITY ASSESSMENT

Mild/Moderate (Outpatient or Short Hospitalization):
  • Eating or able to eat with minimal support
  • Mild dehydration only
  • Spec cPL mildly to moderately elevated
  • No systemic complications
Severe (Requires ICU Hospitalization):
  • Profuse vomiting, unable to eat
  • Moderate to severe dehydration
  • Evidence of SIRS (2 or more: tachycardia/bradycardia, tachypnea, hypothermia/hyperthermia, abnormal WBC)
  • Organ dysfunction (azotemia, hyperbilirubinemia, coagulopathy)
  • Hypotension, shock

PART 4 - STEP-BY-STEP TREATMENT PROTOCOL


STEP 1: FLUID THERAPY (First Priority)

Goal: Correct dehydration, restore pancreatic microcirculation, replace ongoing losses.
Fluid of choice: Isotonic crystalloids
  • Lactated Ringer's Solution (LRS) - preferred
  • 0.9% NaCl - use if hyperkalemia present
  • Plasmalyte - alternative isotonic option
Dosing:
  • Calculate % dehydration (clinical estimate):
    • 5% = mild skin tenting, tacky mucous membranes
    • 8-10% = significant skin tenting, dry MM, sunken eyes
    • 12% = extreme skin tenting, shock signs
  • Deficit (L) = body weight (kg) x % dehydration
  • Replace deficit over 4-8 hours (if no cardiac contraindication)
  • Add maintenance: ~60 ml/kg/day (dogs), ~40-50 ml/kg/day (cats)
  • Add ongoing losses from vomiting/diarrhea
Hypovolemic shock protocol:
  • Dogs: 10-20 ml/kg IV crystalloid bolus, reassess, repeat up to 90 ml/kg total
  • Cats: 5-10 ml/kg IV bolus (cats are more sensitive - avoid fluid overload)
Monitoring: Heart rate, blood pressure, urine output (target >1 ml/kg/hr), lung sounds (avoid overhydration)
Current evidence supports moderate fluid resuscitation - give boluses only in response to hypovolemia indicators, not aggressive volume loading, to reduce fluid overload risk.
Colloids (Hetastarch/Hydroxyethyl starch): 5-10 ml/kg/day if hypoproteinemia (albumin <2 g/dL) or oncotic support needed.

STEP 2: ANALGESIA (Treat Aggressively - Do Not Undertreat)

Abdominal pain should be assumed present in all cases until proven otherwise.

Mild to Moderate Pain:

DrugSpeciesDoseRouteFrequency
Buprenorphine (partial mu-opioid)Dogs & Cats5-30 mcg/kgIV, IM, SC, or OTM (oral transmucosal in cats)Every 4-6 hours
Butorphanol (kappa-opioid, mild)Dogs & Cats0.2-0.4 mg/kgIV, IM, SCEvery 4 hours as needed
Meperidine (Pethidine)Dogs & Cats3-5 mg/kgIM or SC onlyEvery 2 hours as needed
Note: Buprenorphine via OTM (oral transmucosal) is highly effective in cats - place under tongue or on oral mucosa.

Severe Pain - CRI (Continuous Rate Infusion):

DrugLoading DoseCRI DoseNotes
Morphine0.3-0.5 mg/kg IV slowly0.1-1 mg/kg/h IV CRIDogs mainly; avoid in cats (histamine release)
Fentanyl2-10 mcg/kg IV2-10 mcg/kg/h IV CRIBoth species; preferred in cats
Methadone0.1-0.2 mg/kg IV loading0.12 mg/kg/h IV CRIGood option; also mu-opioid
Hydromorphone0.1-0.2 mg/kg IV/IM/SC-Intermittent; suitable mild-moderate

Adjunct Analgesia (CRI add-ons for refractory pain):

DrugDoseNotes
Ketamine4 mg/kg IV bolus + 2-10 mcg/kg/min CRINMDA antagonist; opioid-sparing; use sub-anesthetic doses
Lidocaine2-4 mg/kg IV bolus (slowly) + 2-4 mg/kg/h CRIDogs only; NOT cats (cats are lidocaine-toxic at systemic doses); reduces opioid requirements
Avoid NSAIDs (meloxicam, carprofen, etc.) - contraindicated due to GI adverse effects, risk of AKI in dehydrated patients, and impaired pancreatic perfusion.

STEP 3: ANTI-EMETICS

First-Line:

DrugSpeciesDoseRouteFrequencyMechanism
Maropitant (Cerenia)Dogs & Cats1 mg/kg IV or SC; 2 mg/kg POIV, SC, POEvery 24 hoursNK1 receptor antagonist; also has visceral analgesic properties
OndansetronDogs & Cats0.1-0.5 mg/kgIV (slowly), POEvery 8-12 hours5-HT3 antagonist; good for vomiting refractory to maropitant

Second-Line:

DrugSpeciesDoseNotes
DolasetronDogs & Cats0.6 mg/kg IV5-HT3 antagonist; alternative to ondansetron
MetoclopramideDogs0.2-0.5 mg/kg PO/SC/IM TID, or 1-2 mg/kg/day CRIUse cautiously - dopamine antagonist that may impair pancreatic perfusion; avoid as first-line
Maropitant is the preferred first-line antiemetic for both dogs and cats. It also provides some visceral analgesic benefit.

STEP 4: NUTRITIONAL SUPPORT

Old approach (ABANDONED): "Gut rest" - NPO (nothing by mouth) for 24-72 hours. Current evidence-based approach: Early enteral nutrition as soon as the patient can tolerate it.

Why early feeding?

  • Prolonged NPO causes mucosal atrophy, enterocyte apoptosis, gut barrier dysfunction, and bacterial translocation
  • Early enteral feeding is well tolerated and leads to earlier voluntary food intake and fewer GI complications

Dogs - Feeding Protocol:

  1. Mild pancreatitis: Offer small amounts of low-fat diet (< 20 g fat per 1,000 kcal) within 24 hours
  2. Moderate/severe pancreatitis with vomiting: Once vomiting is controlled (24-48h), attempt oral feeding of low-fat diet in small frequent meals (4-6 x/day)
  3. Cannot eat voluntarily: Place a nasoesophageal (NE) tube or esophagostomy tube for assisted enteral nutrition
  4. Appetite stimulants: Capromorelin (Entyce) 3 mg/kg PO every 24 hours
Avoid high-fat treats, table scraps, or any fatty food during treatment and recovery.

Cats - Feeding Protocol:

  1. Cats MUST eat to avoid hepatic lipidosis - feeding is urgent
  2. Offer hydrolyzed protein diet (moderate fat restriction, not strict low-fat like in dogs)
  3. Appetite stimulants:
    • Mirtazapine: 2 mg/cat PO or transdermally every 24 hours (preferred in cats)
    • Capromorelin (Elura): 2 mg/kg PO every 24 hours
  4. If cat refuses food: nasogastric or esophagostomy tube feeding within 48-72 hours
  5. Treat concurrent triaditis (cholangitis, IBD) simultaneously

STEP 5: ANTIBIOTICS

Not routinely indicated. Pancreatitis is an inflammatory (not primary infectious) process.
Indications for antibiotics:
  • Confirmed aspiration pneumonia
  • Evidence of septic peritonitis
  • Documented bacterial infection (culture-positive)
  • Suspicion of gastrointestinal bacterial translocation (severe, necrotizing pancreatitis with sepsis signs)
  • Pancreatic abscess
Antibiotic choices (when indicated):
DrugDoseRouteFrequencyNotes
Ampicillin-sulbactam22 mg/kgIVEvery 8 hoursBroad-spectrum; first-line for septic patients
Metronidazole10-15 mg/kgIV, POEvery 12 hoursAnaerobic coverage; add-on for gut translocation
EnrofloxacinDogs: 5-10 mg/kg; Cats: 5 mg/kgIV, POEvery 24 hoursCats: do NOT exceed 5 mg/kg/day - retinal toxicity risk
Amoxicillin-clavulanate12.5-25 mg/kgPOEvery 12 hoursFor mild cases/outpatient when antibiotics needed

STEP 6: SPECIFIC TARGETED THERAPY (DOGS ONLY)

Fuzapladib Sodium (Panoquell-CA1) - NEW FDA-Conditionally Approved
  • Mechanism: LFA-1 inhibitor - blocks neutrophil extravasation into inflamed tissue, reducing early inflammatory cascade
  • Indication: Acute-onset pancreatitis in dogs
  • Dose: 0.4 mg/kg IV every 24 hours for 3 days
  • Species: Dogs only (no feline approval)
  • Status: FDA conditional approval (US) and licensed in Japan; reasonable expectation of effectiveness based on pilot studies

STEP 7: ADDITIONAL / SUPPORTIVE MEDICATIONS

Proton Pump Inhibitors (PPIs):

  • Not routinely recommended for pancreatitis unless specific indication (gastric ulceration, reflux esophagitis)
  • Omeprazole: 1 mg/kg PO every 12-24 hours (dogs); 0.7 mg/kg PO every 24 hours (cats) - if indicated
  • Pantoprazole: 1 mg/kg IV every 24 hours - IV option when PO not possible

Prokinetics (for GI ileus):

  • Cisapride: 0.1-0.5 mg/kg PO every 8 hours - helps gastric emptying, esophageal sphincter tone; good for reflux esophagitis
  • Erythromycin: 0.5-1 mg/kg PO/IV every 8 hours - low-dose prokinetic (motilin agonist)
  • Use after adjusting opioid dose if ileus is suspected

Plasma/Fresh Frozen Plasma:

  • Not routinely recommended
  • Consider only in documented DIC (disseminated intravascular coagulation) or severe hypoproteinemia

Corticosteroids:

  • Not routinely recommended for dogs
  • Reserve for: Vasopressor-refractory hypotension, or when conventional therapy fails after ruling out contraindications
  • Cats with chronic pancreatitis: Prednisolone 1-2 mg/kg PO every 24 hours, taper over weeks-months (cats are more responsive to immunosuppression); cyclosporine is an alternative per 2022 ACVIM data
  • Dexamethasone for shock doses in critical patients: 0.1-0.2 mg/kg IV once

Electrolyte Supplementation:

  • Potassium chloride (KCl): Add to IV fluids based on serum K+:
    • K+ 3.0-3.5: add 20 mEq/L
    • K+ 2.5-3.0: add 30 mEq/L
    • K+ 2.0-2.5: add 40 mEq/L
    • K+ < 2.0: add 60 mEq/L (do not exceed 0.5 mEq/kg/h infusion rate)
  • Phosphorus: Supplement if hypophosphatemia detected

Vitamin B12 (Cobalamin):

  • Cats frequently develop cobalamin deficiency with pancreatitis/IBD
  • Cyanocobalamin: 250 mcg SC every 7 days for 4-6 weeks, then monthly
  • Dogs: 250-1500 mcg SC weekly depending on weight

STEP 8: MANAGEMENT OF UNDERLYING CAUSES

Risk FactorAction
HypertriglyceridemiaLow-fat diet; fenofibrate may be added
HypercalcemiaIdentify cause (lymphoma, hyperparathyroidism, vitamin D toxicity); treat accordingly
DrugsDiscontinue phenobarbital, azathioprine, L-asparaginase, or other suspected triggers if possible
Diabetes mellitusConcurrent management; insulin regulation post-pancreatitis
Hypothyroidism (dogs)Thyroid supplementation
Concurrent triaditis (cats)Treat IBD and cholangitis simultaneously

PART 5 - MONITORING DURING TREATMENT

ParameterFrequencyTarget
Body weightEvery 12-24hStable; no fluid overload
Urine outputContinuous/hourly (ICU)> 1-2 ml/kg/hour
Blood pressureEvery 4-8hMAP > 70 mmHg
Heart rateEvery 4-6hDogs: 60-140; Cats: 140-200
Pain scoreEvery 4-6hReassess and adjust analgesia
ElectrolytesEvery 12-24hCorrect K+, Na+, phosphorus
Blood glucoseEvery 4-12hMonitor for transient hyperglycemia or hypoglycemia
PCV/TPEvery 12-24hTrend for improvement in hydration
Spec cPL / Spec fPLEvery 3-5 daysTrending toward normal

PART 6 - SPECIAL CONSIDERATIONS: DOGS vs CATS SUMMARY

FeatureDogsCats
VomitingProminent, repeatedMild or absent
Pain posturePrayer posture classicOccult pain
Diagnostic testSpec cPL (>400 mcg/L)Spec fPL (>28 mcg/L)
DietStrict low-fat (< 20 g fat/1000 kcal)Moderate fat restriction; hydrolyzed protein
Lidocaine CRIYes, safeContraindicated (systemic toxicity)
Appetite stimulantCapromorelin 3 mg/kg/dayMirtazapine 2 mg/cat/day or Capromorelin 2 mg/kg/day
FuzapladibFDA-approvedNot approved
Chronic formLess commonMore common (chronic low-grade)
Concurrent diseaseDM, hyperlipidemia, hypothyroidismTriaditis (IBD + cholangitis + pancreatitis)
Steroid useRarely, refractory onlyMore common; prednisolone for chronic cases

PART 7 - DISCHARGE AND LONG-TERM MANAGEMENT

  1. Continue low-fat diet (dogs) or hydrolyzed/moderate-fat diet (cats) long-term
  2. Oral antiemetics (maropitant 2 mg/kg PO once daily) for 5-7 days if vomiting
  3. Analgesia: Buprenorphine OTM for cats (5-20 mcg/kg every 8 hours) for mild ongoing pain at home; oral tramadol 2-5 mg/kg every 8-12 hours as additional option
  4. Recheck Spec cPL/fPL in 2-4 weeks
  5. Monitor for complications: Diabetes mellitus (post-pancreatitis), exocrine pancreatic insufficiency (EPI), pancreatic pseudocyst
  6. Avoid high-fat diets, treats, table scraps permanently in dogs with recurrent pancreatitis
  7. Cats: Monitor for and manage triaditis long-term; cobalamin supplementation if indicated

Quick Drug Dosage Reference Card

DrugDog DoseCat DoseRoute
Maropitant1 mg/kg IV/SC or 2 mg/kg PO q24h1 mg/kg IV/SC q24hIV/SC/PO
Ondansetron0.1-0.5 mg/kg q8-12h0.1-0.2 mg/kg q8-12hIV/PO
Buprenorphine5-30 mcg/kg q4-6h5-20 mcg/kg q4-8h OTMIV/IM/SC/OTM
Fentanyl CRI2-10 mcg/kg loading + 2-10 mcg/kg/h2-5 mcg/kg loading + 2-5 mcg/kg/hIV CRI
Methadone0.1-0.2 mg/kg loading q4-6h0.1-0.2 mg/kg q6-8hIV/IM
Ketamine CRI4 mg/kg bolus + 2-10 mcg/kg/min2 mg/kg bolus + 2-5 mcg/kg/minIV CRI
LRS / CrystalloidsDeficit + maintenanceDeficit + maintenanceIV
KCl supplementationBased on K+ levelBased on K+ levelIV (in fluids)
Capromorelin3 mg/kg q24h2 mg/kg q24hPO
Mirtazapine1.88 mg/dog q24-48h2 mg/cat q24h (or transdermal)PO/transdermal
Fuzapladib0.4 mg/kg q24h x 3 daysNot approvedIV
PrednisoloneReserve/refractory1-2 mg/kg q24h (chronic)PO
Ampicillin-sulbactam22 mg/kg q8h22 mg/kg q8hIV
Metronidazole10-15 mg/kg q12h10-15 mg/kg q12hIV/PO
Vitamin B12250-1500 mcg q7 days250 mcg q7 daysSC
Omeprazole1 mg/kg q12-24h0.7 mg/kg q24hPO

Disclaimer: This guide is intended for qualified veterinary professionals. All drug doses should be verified against current formularies and adjusted based on individual patient assessment, body weight, organ function, and clinical response. Consult a board-certified veterinary internist for complex or refractory cases.
This is a shared conversation. Sign in to Orris to start your own chat.